Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abbott
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males and females between the ages of 18 and 75 who are diagnosed with mild to moderate Crohn's disease (defined by a CDAI \[Crohn's Disease Activity Index\] score of 220 and 450)
Normal lab parameters
Are willing to give informed consent
Have previously used and either were intolerant to or lost response to infliximab
You may not be if
History of certain types of cancer
Diagnosis of ulcerative colitis
Pregnant female or breast feeding subjects
Known obstructive strictures
Surgical bowel resection in the past 6 months
History of listeria, human immunodeficiency virus (HIV), central nervous system demyelinating disease or untreated TB (tuberculosis)
History of poorly controlled medical conditions
Specific doses and durations of Crohn's medications
Subjects that have previously used infliximab and have never clinically responded unless primary non-response was due to a treatment limiting reaction to infliximab
